投稿ビュー
Sana Biotechnology launches, with focus on engineering cell and gene t - The Pharma Letter
Sana Biotechnology launches, with focus on engineering cell and gene t The Pharma Letter
Former executives of Juno Therapeutics, which was acquired last year by US biotech major Celegene (Nasdaq: CELG), Steve Harr and Hans Bishop, have ...
投稿情報
評価
おすすめ
タグ
転職
"
"@type":
"@type":"NewsArticle"
"Auga Group"
"C" grade Nevada infrastructure
"Errol Oh"
"Jane Goodyear"
"Optimistically Cautious"
"a man and his prostate"
"akcijų pardavimas"
"analytics:simplereach:id":"54
"author":"Art Berman"
"author":"Brad McMillan"
"author":"Bryan Rich"
"author":"Christopher Helman"
"author":"Claire Poole"
"author":"Clare O'Connor"
"author":"David Blackmon"